Skip to main content

Share story

Science

Microplastics in blood linked to higher heart attack risk in new study

Hands full of small plastic pieces Image: Primary
Patients who suffered serious heart attacks had significantly higher levels of micro- and nanoplastic particles in their blood compared to healthy individuals and those with chronic ischemic heart disease, according to a study led by researchers at Sant'Andrea University Hospital and the University of Campania in Italy. The study builds on a 2024 finding that patients with microplastics in arterial plaque faced higher risk of myocardial infarction, stroke, or death within several years. The new research analyzed blood samples from heart attack patients, healthy volunteers, and chronic ischemic heart disease patients, finding the highest microplastic concentrations in the acute heart attack group. "These findings do not prove that microplastics cause heart attacks, but they reveal a strong association between environmental exposures, microplastics in the blood, and cardiovascular disease," said lead author Emanuele Barbato, director of the Cardiology Unit at Sant'Andrea University Hospital. Decades of plastic waste breaking down in the environment has left synthetic polymer particles, fragments too small to see, pervasive in air, water, soil, and food. Researchers have detected microplastics in human lungs, brains, hearts, and placentas. The mechanisms of harm remain under investigation, but researchers hypothesize that the particles trigger inflammatory responses and that embedded petrochemical compounds interfere with biochemical processes. The study adds to a growing body of evidence linking plastic pollution exposure to human health risks, though causal pathways remain to be established.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from New Atlas and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital Products
Capital Products

ID Finance announces €545 million in funding to expand Plazo

Barcelona-based ID Finance announced €545 million in debt and equity funding to expand its consumer finance app Plazo. Participants included Spice Expeditions, WashU, Kingsway Capital and i80 Group, which provided asset-based fina...

Capital
Capital

Undecimal Bio raises €16 million for targeted RNA delivery

Cambridge-based Undecimal Bio announced €16 million ($18 million) in seed financing to expand its platform for delivering RNA medicines to specific cell types. 4BIO Capital and IQ Capital co-led the round, which will also support ...

Capital AI
Capital AI

Clueso raises $10M for AI agents that produce corporate video

Clueso says it raised a $10M Series A led by Dharana Capital, bringing total funding to $12M. More than 80% of the new money came from existing investors increasing their stakes, according to the company. Its agents navigate soft...

Capital AI
Capital AI

CarbonFarm closes €7 million Series A for rice emissions technology

Paris-based CarbonFarm has closed an oversubscribed €7 million Series A led by Colam Impact to expand its rice decarbonisation business. Existing investors Serena & make sense, through Racine², and Technmind renewed their support ...

Capital AI
Capital AI

Obsero raises €1 million to develop AI search marketing agents

British AI search platform and consultancy Obsero has raised €1 million ($1.2 million) in seed funding led by SFC Capital, with participation from several customers. The company plans to develop its first specialist AI agents, dou...